Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,553.20
(
0.96%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
112.38
(
7.63%
)
Bitcoin
75,862.05
(
-0.63%
)
News Focus
News Focus
Post# of 257469
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122909
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 237289

Monday, 07/08/2024 12:46:22 PM

Monday, July 08, 2024 12:46:22 PM

Post# of 257469
LLY acquires MORF for $57/sh cash—a 79% premium to Friday’s closing price:

https://finance.yahoo.com/news/lilly-acquire-morphic-improve-outcomes-104500467.html

MORF’s lead drug is MORF-057, an oral small-molecule drug in phase-2 for UC and Crohn’s disease.

The nominal deal value is $3.2B.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up